

EN

Back



Pumen Technology Gains China Approval for Cancer Diagnostic Control Product

Stock NewsThemesPumen Technology Gains China Approval for Cancer Diagnostic Control Product

Pumen Technology Gains China Approval for Cancer Diagnostic Control Product

Edgen Stock·Jan 05 2026, 15:15

Share to

Share to

Copy link

source:

[1] Pumen Technology (688389.SH): Obtains Medical Device Registration Certificate (https://www.aastocks.com/tc/stocks/analysis/c ...)

Related News

Autolink Targets Next-Decade Vehicles With New Platform

Jan 07 2026, 07:23

Autolink Targets Next-Decade Vehicles With New Platform

Autolink announced its Deep Fusion EEA, an integrated vehicle architecture, planning for mass production within three to five years after securing the second-largest revenue share for intelligent cockpit controllers in China in 2024.

Louis Navellier Backs Nvidia, Palantir for 2026, Urges Exit from 'Junk Rally'

Jan 07 2026, 07:12

Louis Navellier Backs Nvidia, Palantir for 2026, Urges Exit from 'Junk Rally'

Prominent investor Louis Navellier advised investors at the start of 2026 to pivot from speculative 'junk rally' stocks to quality companies with strong earnings growth like Nvidia and Palantir.

Sanofi Targets Growth, Leveraging 40% Flu Vaccine Market Control

Jan 07 2026, 07:09

Sanofi Targets Growth, Leveraging 40% Flu Vaccine Market Control

French drugmaker Sanofi is positioned for a potential revenue boost, controlling 40% of the global flu vaccine market as the U.S. recorded up to 13 million new cases in late 2025.